BNP7787

DRUG2 trials

Sponsors

BioNumerik Pharmaceuticals, Inc., Alliance for Clinical Trials in Oncology

Conditions

AnemiaBreast DiseasesBreast NeoplasmsDrug/Agent Toxicity by Tissue/OrganLung CancerMetastases, NeoplasmNeutropenia

Phase 2

Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

CompletedNCT00077311

Alliance for Clinical Trials in OncologyAnemia, Drug/Agent Toxicity by Tissue/Organ, Lung Cancer +1

Start: 2004-08-31End: 2009-04-30Updated: 2016-06-30

Phase 3

Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel

CompletedNCT00039780

BioNumerik Pharmaceuticals, Inc.Breast Diseases, Breast Neoplasms, Metastases, Neoplasm

Start: 2001-09-30End: 2014-09-30Updated: 2022-07-13